Description
Taxol C is an intermediate in taxane synthesis. Like other taxanes, this compound may also promote microtubule polymerization and prevent microtubule depolymerization, exhibiting anticancer potential, although research is limited.
Product Unit Size | Cost | Quantity | Stock |
---|
Taxol C is an intermediate in taxane synthesis. Like other taxanes, this compound may also promote microtubule polymerization and prevent microtubule depolymerization, exhibiting anticancer potential, although research is limited.
Cas No. | 153415-45-3 |
---|---|
Purity | ≥95% |
Formula | C46H57NO14 |
Formula Wt. | 847.94 |
IUPAC Name | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate |
Synonym | Paclitaxel C, -Pentyl Analog of Paclitaxel; N-Debenzoyl-N-hexanoylpaclitaxel; Taxuyunnanine;Taxuyunnanine A;(-)-Taxuyunnanine;Paclitaxel EP Impurity C. |
Appearance | White Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Slichenmyer WJ, Von Hoff DD. New natural products in cancer chemotherapy. J Clin Pharmacol. 1990 Sep;30(9):770-88. PMID: 1980498.
Shen YC, Chen YJ, Chen CY. Taxane diterpenoids from the seeds of Chinese yew Taxus chinensis. Phytochemistry. 1999 Dec;52(8):1565-9. PMID: 10647221.
PARP1/2 inhibitor.
Synthetic non-steroid endocrine disrupter; ER a...
AChE inhibitor, D2 antagonist.
Read-through agent and nonsense mutation target...
EGFR inhibitor.
Endogenous neuropeptide, involved in opioid sig...
Diterpene found in Taxus, used to synthesize ta...
Naturally sourced ITC, sulfonyl analog of sulfo...
Smo inhibitor.
VEGFR2, PDGFR, FGFR2 inhibitor.
Dibenzofuran produced by lichens.
Benzimidazole; microtubule polymerization inhib...
Sulforaphane homolog, ITC found in cruciferous ...
Endogenous tachykinin peptide, involved in infl...
Sterol cell membrane component found in yeast a...
BRD2/4/9 and CECR2 inhibitor.
MEK1/2 and Raf inhibitor.
Histamine H1-antagonist
EGFR inhibitor.
Microtubule depolymerization inhibitor.